Table I.
Baseline characteristics of the intervention and control group.
| Total 117 (100%) | Intervention 55 (47%) | Control 62 (53%) | df | χ2 | Z | U | p | |
|---|---|---|---|---|---|---|---|---|
| Age, median IQR) | 72 (14) | 70 (14) | 72 (15) | –0.265 | 1.656 | 0.791b | ||
|
| ||||||||
| Female sex, n (%) | 42 (35.9) | 16 (29.1) | 26 (41.9) | 1 | 2.09 | 0.148a | ||
|
| ||||||||
| Diabetes, n (%) | 33 (28.2) | 17 (30.9) | 16 (25.8) | 1 | 0.375 | 0.54a | ||
|
| ||||||||
| Dyslipidemia, n (%) | 38 (32.5) | 16 (29.1) | 22 (35.5) | 1 | 0.543 | 0.461a | ||
|
| ||||||||
| Hypertension, n (%) | 82 (70.1) | 36 (65.5) | 46 (74.2) | 1 | 1.062 | 0.33a | ||
|
| ||||||||
| Basal atrial fibrillation, n (%) | 17 (14.5) | 7 (12.7) | 10 (16.1) | 1 | 0.272 | 0.62a | ||
|
| ||||||||
| Ischemic cardiomyopathy, n (%) | 15 (12.8) | 8 (14.5) | 7 (11.3) | 1 | 0.276 | 0.599a | ||
|
| ||||||||
| Limb arteriopathy, n (%) | 7 (6.0) | 4 (7.3) | 3 (4.8) | 1 | 0.307 | 0.75a | ||
|
| ||||||||
| Previous stroke, n (%) | 24 (20.5) | 12 (21.8) | 12 (19.4) | 1 | 0.108 | 0.742a | ||
|
| ||||||||
| Smokers, n (%) | 24 (20.5) | 14 (25.5) | 10 (16.1) | 1 | 1.555 | 0.212a | ||
|
| ||||||||
| Benzodiazepines intake in the last three months, n (%) | 21 (17.9) | 13 (23.6) | 8 (12.9) | 1 | 2.28 | 0.131a | ||
|
| ||||||||
| Opioids intake in the last three months, n (%) | 9 (7.7) | 8 (14.5) | 1 (1.6) | 1 | 6.865 | 0.012a | ||
|
| ||||||||
| Facial palsy, n (%) | 65 (55.6) | 28 (50.9) | 37 (59.7) | 1 | 0.908 | 0.341a | ||
|
| ||||||||
| Baseline NIHSS, median (IQR) | 4 (4) | 5 (5) | –0.746 | 1.569 | 0.456b | |||
|
| ||||||||
| Large vessel occlusion, n (%) | 34 (29.1) | 16 (29.1) | 18 (29) | 1 | 0 | 0.994a | ||
|
| ||||||||
| Hyperacute endovascular treatment, n (%) | 21 (17.9) | 8 (14.5) | 13 (21) | 1 | 0.816 | 0.366a | ||
|
| ||||||||
| Thrombolysis, n (%) | 18 (15.4) | 10 (18.2) | 8 (12.9) | 1 | 0.624 | 0.43a | ||
df: degrees of freedom; IQR: Interquartile range.
a
Chi-Squared test,
b
Mann-Whitney U test.